Clinical impact of the metabolic phenotype of prostate cancer: role of monocarboxylate transporters (MCTs)

Benzer Materyaller

• Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?
  Yazar:: Nelma Pértega-Gomes, ve diğerleri
  Baskı/Yayın Bilgisi: (2014-10-01)
• Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?
  Yazar:: Pértega-Gomes, Nelma, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer
  Yazar:: Pértega-Gomes, Nelma, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets
  Yazar:: Miranda-Gonçalves, Vera, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy
  Yazar:: Pertega‐Gomes, Nelma, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)